Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to -$0.12.

  • Silo Pharma's EPS (Basic) rose 4545.45% to -$0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.95, marking a year-over-year increase of 2016.81%. This contributed to the annual value of -$1.19 for FY2024, which is 53.41% up from last year.
  • According to the latest figures from Q3 2025, Silo Pharma's EPS (Basic) is -$0.12, which was up 4545.45% from -$0.19 recorded in Q2 2025.
  • In the past 5 years, Silo Pharma's EPS (Basic) registered a high of $3.24 during Q3 2021, and its lowest value of -$0.58 during Q4 2022.
  • For the 5-year period, Silo Pharma's EPS (Basic) averaged around -$0.1, with its median value being -$0.29 (2023).
  • Per our database at Business Quant, Silo Pharma's EPS (Basic) skyrocketed by 3250000.0% in 2021 and then plummeted by 681853.6% in 2022.
  • Silo Pharma's EPS (Basic) (Quarter) stood at -$0.47 in 2021, then decreased by 23.4% to -$0.58 in 2022, then soared by 34.48% to -$0.38 in 2023, then fell by 23.74% to -$0.47 in 2024, then soared by 74.48% to -$0.12 in 2025.
  • Its EPS (Basic) was -$0.12 in Q3 2025, compared to -$0.19 in Q2 2025 and -$0.23 in Q1 2025.